HOMOLOGY MEDICINES

DEAD

Serial Number

87791657

Owner

Homology Medicines, Inc.

Attorney

Jenevieve Maerker,

First Use Date

Jul 18, 2019

Filing Date

Feb 9, 2018

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

HOMOLOGY MEDICINES Trademark

Serial Number: 87791657 • Registration: 5910664

HOMOLOGY MEDICINES is a trademark filed by Homology Medicines, Inc. on February 9, 2018. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

Homology Medicines, Inc. (8 trademarks)

Bedford, MA 01730

Entity Type: 03

Legal Representation

Attorney of Record

Jenevieve Maerker,

2 trademarks filed View all →

Correspondence Address

Jenevieve Maerker, FOLEY HOAG LLP

155 SEAPORT BOULEVARD

BOSTON, MA 02210-2600

UNITED STATES

Trademark Details

Filing Date

February 9, 2018

Registration Date

November 12, 2019

First Use Anywhere

July 18, 2019

First Use in Commerce

July 18, 2019

Cancellation Date

May 22, 2026

Goods & Services

House mark for pharmaceuticals

Filing History

CANCELLED SEC. 8 (6-YR)

May 22, 2026 C8..

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Nov 12, 2024 REM1

REGISTERED-SUPPLEMENTAL REGISTER

Nov 12, 2019 R.SR

LAW OFFICE PUBLICATION REVIEW COMPLETED

Oct 7, 2019 PREV

ASSIGNED TO LIE

Sep 30, 2019 ALIE

NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED

Sep 25, 2019 AAUA

APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER

Sep 24, 2019 CNTA

EXAMINER'S AMENDMENT ENTERED

Sep 24, 2019 XAEC

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Sep 24, 2019 GNEN

EXAMINERS AMENDMENT E-MAILED

Sep 24, 2019 GNEA

EXAMINERS AMENDMENT -WRITTEN

Sep 24, 2019 CNEA

NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED

Sep 24, 2019 AAUA

EXAMINER'S AMENDMENT ENTERED

Sep 21, 2019 XAEC

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Sep 21, 2019 GNEN

EXAMINERS AMENDMENT E-MAILED

Sep 21, 2019 GNEA

EXAMINERS AMENDMENT -WRITTEN

Sep 21, 2019 CNEA

USE AMENDMENT ACCEPTED

Sep 21, 2019 IUAA

TEAS/EMAIL CORRESPONDENCE ENTERED

Aug 7, 2019 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Aug 6, 2019 CRFA

TEAS REQUEST FOR RECONSIDERATION RECEIVED

Aug 6, 2019 ERFR

AMENDMENT TO USE PROCESSING COMPLETE

Aug 6, 2019 AUPC

USE AMENDMENT FILED

Aug 6, 2019 IUAF

TEAS AMENDMENT OF USE RECEIVED

Aug 5, 2019 EAAU

NOTIFICATION OF FINAL REFUSAL EMAILED

Feb 6, 2019 GNFN

FINAL REFUSAL E-MAILED

Feb 6, 2019 GNFR

FINAL REFUSAL WRITTEN

Feb 6, 2019 CNFR

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Dec 10, 2018 CHAN

TEAS CHANGE OF OWNER ADDRESS RECEIVED

Dec 10, 2018 COAR

TEAS/EMAIL CORRESPONDENCE ENTERED

Dec 1, 2018 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Nov 30, 2018 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Nov 30, 2018 TROA

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Jun 3, 2018 GNRN

NON-FINAL ACTION E-MAILED

Jun 3, 2018 GNRT

NON-FINAL ACTION WRITTEN

Jun 3, 2018 CNRT

ASSIGNED TO EXAMINER

May 24, 2018 DOCK

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Feb 16, 2018 NWOS

NEW APPLICATION ENTERED

Feb 13, 2018 NWAP

Related Trademarks

More from this Owner

HOMOLOGY MEDICINES, INC.

More in Same Class

VEGAMA